Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Putative keratin-associated protein 20-4 (KRTAP20-4) belongs to the high glycine-tyrosine (HGT) keratin-associated protein (KAP) family, which forms part of the matrix that embeds hair keratin intermediate filaments within the hair cortex[3][2]. KRTAP20 subfamily proteins are characterized by a high content of glycine and tyrosine residues, contributing to their structural role in hair fiber morphology[2]. The primary function of these proteins is to help build the rigid yet flexible structure of the hair by supporting and crosslinking keratin intermediate filaments[3][2]. This gene is mostly studied for its influence on traits of animal fibers, such as wool diameter and yield in livestock. There is currently no evidence to support KRTAP20-4 as a therapeutic target, nor is it implicated in specific diseases or associated with any drugs[3][2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative keratin-associated protein 20-4 (KRTAP20-4).